Exclusive - Centerbridge prepares wind turbine group Senvion for IPO: sources

Reuters

Published Nov 23, 2015 11:52

Exclusive - Centerbridge prepares wind turbine group Senvion for IPO: sources

By Freya Berry and Arno Schuetze

LONDON/FRANKFURT (Reuters) - Buyout firm Centerbridge is exploring a listing of German wind turbine company Senvion less than a year after acquiring the company for 1 billion euros (£702.5 million), two sources familiar with the matter said on Monday.

The private equity firm is working with JP Morgan (N:JPM) and Deutsche Bank (DE:DBKGn) on the potential exit, which may value Senvion, formerly known as Repower, at roughly 1.5 billion euros, the people said.

While an initial public offering is seen as the most likely option, Centerbridge may decide on an outright sale or to keep the asset, the sources said, adding a note of caution because deliberations are at a very early stage.

Centerbridge, JP Morgan and Deutsche Bank declined to comment.

Consolidation in the wind turbine sector, which has suffered from overcapacity, is gaining pace as companies emerge from years of cost-cutting and earnings improve.

Last month, Germany's Nordex (DE:NDXG) bought Spanish firm Acciona's (MC:ANA) wind power business for 785 million euros to create a global player in the wind energy market.

New York-based Centerbridge purchased Senvion from loss-making Indian parent Suzlon Energy (NS:SUZL) only in January.

Private equity firms typically aim to hold companies for four to six years, although that time has been coming down as funds take advantage of a strong sellers' market to make a quick return on assets.

Buyout house Bain, for example, listed British brick manufacturer Ibstock (L:IBST) in October, after buying the company in December 2014 from Irish construction group CRH (I:CRH).

"It's like Ibstock, it's becoming a new world for sponsors where they can simply take advantage of the markets," one of the sources said of the speed of Centerbridge's planned exit.

Another source familiar with the matter said that Centerbridge had bought Senvion on the cheap and a quick disposal may help it maximise its internal rate of return, a measure private equity groups use to identify investment success over time.

In July Senvion announced adjusted core earnings (EBITDA) of 155 million euros, up 6.2 percent on the previous fiscal year, and revenues of 1.9 billion euros. An industry banker noted that the business had won several projects since the acquisition.

Rivals like Nordex, Vestas (CO:VWS), Goldwind or Ming Yang (N:MY) trade at an average of 9.4 times their expected core earnings and if Senvion would fetch a similar valuation it could sell for roughly 1.5 billion euros.

Get The App
Join the millions of people who stay on top of global financial markets with Investing.com.
Download Now

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes